Mitochondria lose a key membrane lipid with age
Mitochondria, the energy-producing structures inside cells, decline with age. New research identifies a specific lipid molecule as a likely culprit: phosphatidylcholine, the most abundant fat in mitochondrial membranes, drops significantly as organisms age. In worms, restoring it improved mitochondrial function.
Mitochondrial decline is one of the most well-established hallmarks of biological aging. Yet the molecular causes remain poorly understood. Genetic mutations explain only part of the picture. A new study points to membrane composition as a neglected factor.
Phosphatidylcholine is critical for the structural stability and permeability of mitochondrial membranes. When its levels fall, membranes become less stable, disrupting the electrochemical gradients that drive energy production. The study found that levels of this lipid fall substantially in older Caenorhabditis elegans worms compared to young ones.
A self-reinforcing decline
The researchers also identified a compounding mechanism. Mitochondria produce phosphatidylcholine themselves through specific enzymes. Those enzymes become less active with age, meaning older mitochondria make less of the lipid they need to function. Less lipid leads to worse mitochondria, which produce even less lipid.
In laboratory experiments using human cells, the pattern appeared to hold, though these findings are preliminary. Restoring phosphatidylcholine levels in worms rescued measurable aspects of mitochondrial function.
Supplementation as a research direction
Phosphatidylcholine is already available as a dietary supplement, commonly found in lecithin products. That makes it an accessible target for further study. Researchers urge caution: the jump from worm biology to human physiology is significant, and it remains unclear whether oral supplementation effectively reaches mitochondria in sufficient concentrations.
Still, pinpointing this specific membrane lipid as a driver of mitochondrial aging gives researchers a concrete molecular target. It connects lipid metabolism to the broader biology of cellular energy decline, which is relevant to aging, metabolic disease, and neurodegeneration.